NYSE:ABBV - AbbVie News Headlines

Sign in or create an account to add this stock to your watchlist.
$80.85 +0.33 (+0.41 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$80.85
Today's Range$80.16 - $81.70
52-Week Range$75.77 - $122.00
Volume6.30 million shs
Average Volume7.71 million shs
Market Capitalization$121.62 billion
P/E Ratio10.22
Dividend Yield5.32%
Beta1.17

Headlines

AbbVie (NYSE ABBV) News Headlines

Source:
DateHeadline
AbbVie Inc. -- Moodys announces completion of a periodic review of ratings of AbbVie Inc.AbbVie Inc. -- Moody's announces completion of a periodic review of ratings of AbbVie Inc.
finance.yahoo.com - February 16 at 5:10 AM
AbbVie Is Too Risky Right NowAbbVie Is Too Risky Right Now
seekingalpha.com - February 14 at 3:10 PM
AbbVie (ABBV) Earns Hold Rating from BarclaysAbbVie (ABBV) Earns Hold Rating from Barclays
www.americanbankingnews.com - February 14 at 7:55 AM
AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
finance.yahoo.com - February 13 at 3:15 PM
AbbVie Suffers Market Loss For Humira In Europe, But The U.S. Is A Different StoryAbbVie Suffers Market Loss For Humira In Europe, But The U.S. Is A Different Story
seekingalpha.com - February 12 at 5:04 AM
AbbVie on go to start clinical development of Parkinsons candidate ABBV-0805AbbVie on go to start clinical development of Parkinson's candidate ABBV-0805
seekingalpha.com - February 11 at 3:10 PM
Here's Why Coherus BioSciences Rose 48.7% in JanuaryHere's Why Coherus BioSciences Rose 48.7% in January
finance.yahoo.com - February 11 at 3:10 PM
AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple MyelomaAbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma
finance.yahoo.com - February 11 at 9:51 AM
Heres Why AbbVies Stock Tanked in JanuaryHere's Why AbbVie's Stock Tanked in January
www.fool.com - February 9 at 3:06 PM
Here's Why AbbVie's Stock Tanked in JanuaryHere's Why AbbVie's Stock Tanked in January
finance.yahoo.com - February 9 at 3:06 PM
$7.78 Billion in Sales Expected for AbbVie Inc (ABBV) This Quarter$7.78 Billion in Sales Expected for AbbVie Inc (ABBV) This Quarter
www.americanbankingnews.com - February 9 at 2:14 AM
After Humira: AbbVies Upa Vs. Gileads FilgoAfter Humira: AbbVie's Upa Vs. Gilead's Filgo
seekingalpha.com - February 8 at 3:05 PM
What Are the Key Growth Drivers for AbbVie in 2019?What Are the Key Growth Drivers for AbbVie in 2019?
finance.yahoo.com - February 8 at 3:05 PM
Does FedEx look good here? What's the deal with McKesson? Buy Abbvie?Does FedEx look good here? What's the deal with McKesson? Buy Abbvie?
finance.yahoo.com - February 8 at 3:05 PM
Is AbbVie or Celgene Expected to Report Faster Revenue Growth?Is AbbVie or Celgene Expected to Report Faster Revenue Growth?
finance.yahoo.com - February 8 at 5:14 AM
Zacks: Brokerages Anticipate AbbVie Inc (ABBV) Will Announce Earnings of $2.04 Per ShareZacks: Brokerages Anticipate AbbVie Inc (ABBV) Will Announce Earnings of $2.04 Per Share
www.americanbankingnews.com - February 7 at 11:18 PM
Testosterone Replacement Therapy Market 2019 Analysis by Top Manufacturers Endo International, AbbVie, Eli lilly, Pfizer, Bayer, and more...Testosterone Replacement Therapy Market 2019 Analysis by Top Manufacturers Endo International, AbbVie, Eli lilly, Pfizer, Bayer, and more...
www.marketwatch.com - February 7 at 5:08 AM
At least four pharma CEOs to testify at Senate drug pricing hearingAt least four pharma CEOs to testify at Senate drug pricing hearing
finance.yahoo.com - February 6 at 3:14 PM
Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Heres what theyre sayingCongress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying
finance.yahoo.com - February 6 at 3:14 PM
Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm - PRNewswireJohnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm - PRNewswire
www.prnewswire.com - February 6 at 5:19 AM
Pharma execs will testify before Congress one way or another, US senator saysPharma execs will testify before Congress 'one way or another,' US senator says
finance.yahoo.com - February 5 at 3:15 PM
Merck CEO Frazier plans to testify at Senate drug pricing hearingMerck CEO Frazier plans to testify at Senate drug pricing hearing
finance.yahoo.com - February 5 at 3:15 PM
Bulls & Bears Of The Week: AT&T, Facebook, GE, Microsoft And MoreBulls & Bears Of The Week: AT&T, Facebook, GE, Microsoft And More
finance.yahoo.com - February 3 at 3:07 PM
Is AbbVie a Buy?Is AbbVie a Buy?
www.fool.com - February 3 at 9:50 AM
Pricing Pressure a Hard Pill for Pharma to SwallowPricing Pressure a Hard Pill for Pharma to Swallow
finance.yahoo.com - February 2 at 5:09 AM
The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General DynamicsThe Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics
finance.yahoo.com - February 1 at 3:13 PM
Top Research Reports for Union Pacific, AbbVie & General DynamicsTop Research Reports for Union Pacific, AbbVie & General Dynamics
finance.yahoo.com - January 31 at 3:08 PM
AbbVies Existential Tests Are Upon ItAbbVie's Existential Tests Are Upon It
seekingalpha.com - January 31 at 5:07 AM
A Look at AbbVie’s Diversified Product Portfolio in Fiscal 2019A Look at AbbVie’s Diversified Product Portfolio in Fiscal 2019
finance.yahoo.com - January 30 at 3:10 PM
3 Big Pharmas Expecting a Softer 20193 Big Pharmas Expecting a Softer 2019
finance.yahoo.com - January 30 at 3:10 PM
AbbVie Reports Improvement in Margins in Fiscal 2018AbbVie Reports Improvement in Margins in Fiscal 2018
finance.yahoo.com - January 30 at 3:10 PM
Genentech kills big drug study in early Alzheimer's patientsGenentech kills big drug study in early Alzheimer's patients
finance.yahoo.com - January 30 at 3:10 PM
AbbVie (ABBV) Price Target Cut to $8.67 by Analysts at ArgusAbbVie (ABBV) Price Target Cut to $8.67 by Analysts at Argus
www.americanbankingnews.com - January 30 at 8:33 AM
William Blair Weighs in on AbbVie Incs Q1 2019 Earnings (ABBV)William Blair Weighs in on AbbVie Inc's Q1 2019 Earnings (ABBV)
www.americanbankingnews.com - January 30 at 7:12 AM
Cramers lightning round: AbbVie needs to make an acquisition—it might just save its stockCramer's lightning round: AbbVie needs to make an acquisition—it might just save its stock
www.cnbc.com - January 29 at 7:13 PM
Imbruvica Is Key Growth Driver for AbbVie in Fiscal 2019Imbruvica Is Key Growth Driver for AbbVie in Fiscal 2019
finance.yahoo.com - January 29 at 3:07 PM
Jacksonville's increasing use of LNG as a transportation fuelJacksonville's increasing use of LNG as a transportation fuel
finance.yahoo.com - January 29 at 3:07 PM
Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/YBiogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y
finance.yahoo.com - January 29 at 3:07 PM
Brokers Issue Forecasts for AbbVie Incs Q1 2020 Earnings (ABBV)Brokers Issue Forecasts for AbbVie Inc's Q1 2020 Earnings (ABBV)
www.americanbankingnews.com - January 29 at 8:24 AM
AbbVie: Tough 2019 AheadAbbVie: Tough 2019 Ahead
seekingalpha.com - January 29 at 5:10 AM
AbbVie Missed Revenue Estimates in Q4 2018AbbVie Missed Revenue Estimates in Q4 2018
finance.yahoo.com - January 29 at 5:10 AM
Analysts Cut AbbVie Price Targets After Earnings MissAnalysts Cut AbbVie Price Targets After Earnings Miss
finance.yahoo.com - January 28 at 3:00 PM
3 Reasons I Just Tripled Down On AbbVie3 Reasons I Just Tripled Down On AbbVie
seekingalpha.com - January 28 at 5:16 AM
Edited Transcript of ABBV earnings conference call or presentation 25-Jan-19 2:00pm GMTEdited Transcript of ABBV earnings conference call or presentation 25-Jan-19 2:00pm GMT
finance.yahoo.com - January 28 at 5:16 AM
3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore
finance.yahoo.com - January 28 at 5:16 AM
Q1 2019 EPS Estimates for AbbVie Inc Cut by Piper Jaffray Companies (ABBV)Q1 2019 EPS Estimates for AbbVie Inc Cut by Piper Jaffray Companies (ABBV)
www.americanbankingnews.com - January 28 at 2:16 AM
Credit Suisse Group Reiterates $79.00 Price Target for AbbVie (ABBV)Credit Suisse Group Reiterates $79.00 Price Target for AbbVie (ABBV)
www.americanbankingnews.com - January 27 at 11:46 PM
3 Reasons AbbVie Investors Arent Too Worried About Humira Anymore3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore
www.fool.com - January 27 at 7:35 PM
AbbVie: Not Driving Via The Rearview MirrorAbbVie: Not Driving Via The Rearview Mirror
seekingalpha.com - January 27 at 3:14 PM
Forget Humira -- Here's What You Need to Know About AbbVieForget Humira -- Here's What You Need to Know About AbbVie
finance.yahoo.com - January 27 at 3:14 PM
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel